IMVT logo

IMVT
Immunovant Inc

2,214
Mkt Cap
$5.4B
Volume
1.58M
52W High
$29.25
52W Low
$13.36
PE Ratio
-9.90
IMVT Fundamentals
Price
$27.43
Prev Close
$26.55
Open
$26.89
50D MA
$25.62
Beta
1.07
Avg. Volume
1.3M
EPS (Annual)
-$2.73
P/B
5.47
Rev/Employee
$0.00
$1,876.52
Loading...
Loading...
News
all
press releases
Melanie Gloria Sells 8,722 Shares of Immunovant (NASDAQ:IMVT) Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) COO Melanie Gloria sold 8,722 shares of the business's stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $24.83, for a total transaction of $216,567.26. Following the completion of the transaction, the chief...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Insider Selling: Immunovant (NASDAQ:IMVT) COO Sells 8,722 Shares of Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) COO Melanie Gloria sold 8,722 shares of the stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $24.83, for a...
MarketBeat·5d ago
News Placeholder
Jay Stout Sells 10,132 Shares of Immunovant (NASDAQ:IMVT) Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) CTO Jay Stout sold 10,132 shares of the company's stock in a transaction dated Wednesday, April 8th. The shares were sold at an average price of...
MarketBeat·5d ago
News Placeholder
Insider Selling: Immunovant (NASDAQ:IMVT) Insider Sells 5,165 Shares of Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) insider Tuyl Christopher Van sold 5,165 shares of the business's stock in a transaction on Wednesday, April 8th. The stock was sold at an average...
MarketBeat·5d ago
News Placeholder
JPMorgan Chase & Co. Sells 402,933 Shares of Immunovant, Inc. $IMVT
JPMorgan Chase & Co. decreased its holdings in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 84.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·6d ago
News Placeholder
Immunovant, Inc. (NASDAQ:IMVT) Receives Consensus Recommendation of "Hold" from Brokerages
Shares of Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) have been assigned a consensus rating of "Hold" from the eleven brokerages that are currently covering the stock, Marketbeat.com reports...
MarketBeat·8d ago
News Placeholder
IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints
Immunovant slips 2.4% after batoclimab misses key phase III endpoints in thyroid eye disease trials, despite stable safety and signs of biological activity.
Zacks·9d ago
News Placeholder
Aberdeen Group plc Increases Stake in Immunovant, Inc. $IMVT
Aberdeen Group plc grew its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 20.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,184,122 shares...
MarketBeat·11d ago
News Placeholder
Eric Venker Sells 14,229 Shares of Immunovant (NASDAQ:IMVT) Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) CEO Eric Venker sold 14,229 shares of the business's stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of...
MarketBeat·11d ago
News Placeholder
Immunovant (NASDAQ:IMVT) CEO Sells $342,918.90 in Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) CEO Eric Venker sold 14,229 shares of the firm's stock in a transaction that occurred on Thursday, April 2nd. The stock was sold at an average price...
MarketBeat·12d ago
<
1
2
...
>

Latest IMVT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.